![Margaret Pax](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margaret Pax
Directeur/Membre du Conseil chez
REPLIGEN CORPORATION
Fortune : 373 213 $ au 31/05/2026
Profil
Ms. Margaret A. Pax is an Independent Director at Repligen Corp.
and an Independent Director at Jellagen Pty Ltd. She is on the Board of Directors at Repligen Corp., BioPorto, Inc., Harvard Business School Health Industry Alumni Association and Jellagen Pty Ltd. Ms. Pax was previously employed as an Independent Director by Alimera Sciences, Inc., a Vice President-Business Development by Microchips Biotech, Inc., and a Vice President-Marketing by OmniSonics Medical Technologies, Inc. She also served on the board at Bioporto A/S.
She received her undergraduate degree from the College of the Holy Cross (Massachusetts) and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REPLIGEN CORPORATION 0,01 % | 14/05/2026 | 3 011 ( 0,01 % ) | 373 213 $ | 31/05/2026 |
Postes actifs de Margaret Pax
| Sociétés | Poste | Début |
|---|---|---|
| REPLIGEN CORPORATION | Directeur/Membre du Conseil | 18/03/2024 |
Bioporto, Inc. | Directeur/Membre du Conseil | - |
Jellagen Pty Ltd.
 Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Directeur/Membre du Conseil | - |
Harvard Business School Health Industry Alumni Association | Directeur/Membre du Conseil | - |
Anciens postes connus de Margaret Pax
| Sociétés | Poste | Fin |
|---|---|---|
| ALIMERA SCIENCES, INC. | Directeur/Membre du Conseil | 16/09/2024 |
| BIOPORTO A/S | Directeur/Membre du Conseil | - |
OmniSonics Medical Technologies, Inc.
 OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Sales & Marketing | - |
Microchips Biotech, Inc.
 Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Corporate Officer/Principal | - |
Formation de Margaret Pax
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Consumer Non-Durables |
Bioporto, Inc. |
